ImaFlow Corefacility on Muck Rack

ImaFlow Corefacility

As seen in: British Pharmacological Society
Is this you? As a journalist, you can create a free Muck Rack account to customize your profile, list your contact preferences, and upload a portfolio of your best work. Claim your profile

Get in touch with ImaFlow

Contact ImaFlow, search articles and posts on X, monitor coverage, and track replies from one place.

Learn more about Muck Rack

Actions

Share this page

Is this you?

As a journalist, you can create a free Muck Rack account to customize your profile, list your contact preferences, and upload a portfolio of your best work.
Claim your profile

Articles

Blockade of cannabinoid CB

|
By Océane Pointeau, Université Bourgogne Europe, Audrey Geissler, ImaFlow Corefacility
| British Pharmacological Society
AGEs advanced glycation end products ANGPT1 angiopoietin 1 Ccr creatinine clearance CKD chronic kidney disease DN diabetic nephropathy FGF20 fibroblast growth factor 20 PAI-1 plasminogen activator inhibitor 1 PTEC proximal tubular cells RAAS renin-angiotensin-aldosterone system SGLT2 sodium-glucose cotransporter type 2 What is already known? SGLT2 inhibitors and peripheral CB1 receptor blockers show kidney protection, including anti-fibrotic effects.
Open in Who Shared Issue with article?
See all 1 articles

Actions

Share this page

Is this you?

As a journalist, you can create a free Muck Rack account to customize your profile, list your contact preferences, and upload a portfolio of your best work.
Claim your profile

Get in touch with ImaFlow

Contact ImaFlow, search articles and posts on X, monitor coverage, and track replies from one place.

Learn more about Muck Rack
 •  Privacy  •  Terms  •  Security and Legal  •   •   •   • 

© 2026 Muck Rack

SOC 2® Certified